Showing results (331-340 of 403) with videos related to
Sort By:
Pageof 41
Journal of Intensive Care|March 8, 2024
Risk factors for arterial catheter failure and complications during critical care hospitalisation: a secondary analysis of a multisite, randomised trialJessica A Schults, Emily R Young, Nicole Marsh, et al.International Journal of Particle Therapy|April 8, 2021
Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical ProstatectomyShivam M Kharod, Catherine E Mercado, Christopher G Morris, et al.Journal of Neurointerventional Surgery|June 21, 2020
The WOVEN trial: Wingspan One-year Vascular Events and Neurologic OutcomesMichael J Alexander, Alois Zauner, Rishi Gupta, et al.International Journal of Particle Therapy|December 4, 2020
Image-Guided Hypofractionated Proton Therapy in Early-Stage Non-Small Cell Lung Cancer: A Phase 2 StudyShivam M Kharod, R Charles Nichols, Randal H Henderson, et al.Cancer|December 12, 2007
Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge ConferenceSteven E Come, Aman U Buzdar, James N Ingle, et al.Metallomics : Integrated Biometal Science|May 10, 2021
Zinc stable isotope analysis reveals Zn dyshomeostasis in benign tumours, breast cancer, and adjacent histologically normal tissueKaj V Sullivan, Rebekah E T Moore, Miles S Capper, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2016
Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell CountsJacqueline A Shaw, David S Guttery, Allison Hills, et al.International Journal of Particle Therapy|November 28, 2019
Bacterial Urinary Tract Infection after Transrectal Placement of Fiducial Markers prior to Proton Radiotherapy for Prostate CancerWilliam M Mendenhall, Gabriella Glassman, Christopher G Morris, et al.Clinical Breast Cancer|May 17, 2011
Management and outcome of HER2-positive early breast cancer treated with or without trastuzumab in the adjuvant trastuzumab eraCarlo Palmieri, Deep Shah, Jonathan Krell, et al.The Lancet. Oncology|June 1, 2005
Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trialAndreas Polychronis, H Dudley Sinnett, Dimitri Hadjiminas, et al.Pageof 41